Search - tctmd.com

Displaying 1 - 20 of 85

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Biggest News of 2025

Michael O'Riordan

January 01, 2026

News Conference News EuroPCR 2025

Stroke Risk Higher With TAVI vs Surgery at 5 Years: UK TAVI

Michael O'Riordan

May 23, 2025

News Opinion Off Script

Q&A: Wayne Batchelor Reflects on the State of Medical Research Early in the Second Trump Term

Wayne Batchelor, MD, MHS, MBA

February 07, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2025

Shelley Wood

January 31, 2025

News Daily News

Early Actions by Trump Administration Sow Uncertainty for CV Research

Todd Neale

January 30, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for June 2024

Shelley Wood

July 02, 2024

News Daily News

Knowns and Unknowns in Subclinical Aortic Valve Thrombosis

Caitlin E. Cox

June 21, 2024

News Daily News

Semaglutide Winning Streak Continues in CKD With FLOW

Shelley Wood

March 06, 2024

News Daily News

Low Bleeding Profile With Asundexian Seen in Pooled Analysis

L.A. McKeown

February 13, 2024

AZALEA-TIMI 71: Abelacimab Slashes Bleeds vs Rivaroxaban in AF, but Stroke Impact Unclear

News Conference News AHA 2023

NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear

L.A. McKeown

November 12, 2023

News Daily News

FDA Approves Paradise Renal Denervation System: What Comes Next?

Todd Neale

November 08, 2023

News Daily News

TCTMD’s Top 10 Most Popular Stories for September 2023

Shelley Wood

October 03, 2023

News Daily News

‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF

L.A. McKeown

September 18, 2023

News Daily News

Obicetrapib Effective When Added to Statins and Ezetimibe: ROSE2

Michael O'Riordan

June 14, 2023

News Features

Some Rays of Hope for ‘Sorry State’ of Transplant Rejection

Shelley Wood

May 08, 2023

News Opinion CV Team Dispatch

December 2022 News Roundup

L.A. McKeown

December 28, 2022

News Conference News AHA 2022

Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI

L.A. McKeown

November 07, 2022

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal Care Resumes

News Daily News

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal BP Care Resumes

Michael O'Riordan

October 18, 2022

News Daily News

New Biomarker Data Again Draw Eyes to Mineral Oil in REDUCE-IT

Caitlin E. Cox

July 08, 2022

News Daily News

Subclinical Thrombosis After TAVI Benign, at Least to 3 Years

Michael O'Riordan

June 07, 2022

Advertisement

TCTMD’s Biggest News of 2025

Stroke Risk Higher With TAVI vs Surgery at 5 Years: UK TAVI

Q&A: Wayne Batchelor Reflects on the State of Medical Research Early in the Second Trump Term

TCTMD’s Top 10 Most Popular Stories for January 2025

Early Actions by Trump Administration Sow Uncertainty for CV Research

TCTMD’s Top 10 Most Popular Stories for June 2024

Knowns and Unknowns in Subclinical Aortic Valve Thrombosis

Semaglutide Winning Streak Continues in CKD With FLOW

Low Bleeding Profile With Asundexian Seen in Pooled Analysis

NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear

FDA Approves Paradise Renal Denervation System: What Comes Next?

TCTMD’s Top 10 Most Popular Stories for September 2023

‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF

Obicetrapib Effective When Added to Statins and Ezetimibe: ROSE2

Some Rays of Hope for ‘Sorry State’ of Transplant Rejection

December 2022 News Roundup

Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal BP Care Resumes

New Biomarker Data Again Draw Eyes to Mineral Oil in REDUCE-IT

Subclinical Thrombosis After TAVI Benign, at Least to 3 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content